1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow Vascular Neoplasms: new trials by email Literature Review of Vascular Neoplasms trials Research Report on Vascular Neoplasms
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pembrolizumab in Treating Patients With Rare Tumors That Cannot Be Removed by Surgery or Are Metastatic Laboratory Biomarker Analysis, Pembrolizumab, Questionnaire Administration - Advanced Malignant Solid Neoplasm, Carcinoma of Unknown Primary | Phase 2 | Active not recruiting | M.D. Anderson Cancer Center | 157 | 2016-08-15 | 2026-07-17 |
Adrenal Cortex Neoplasms (1) · Carcinoma, Renal Cell (1) · Carcinoma, Small Cell (1) · Neoplasm Metastasis (1) · Neoplasms, Unknown Primary (1) · Paraganglioma (1) · Penile Neoplasms (1) · Pheochromocytoma (1)
Adenocarcinoma (1) · Adrenal Cortex Diseases (1) · Adrenal Gland Diseases (1) · Adrenal Gland Neoplasms (1) · Carcinoma (1) · Cardiovascular Diseases (1) · Endocrine Gland Neoplasms (1) · Endocrine System Diseases (1) · Female Urogenital Diseases (1) · Female Urogenital Diseases and Pregnancy Complications (1) · Genital Diseases (1) · Genital Diseases, Male (1) · Genital Neoplasms, Male (1) · Kidney Diseases (1) · Kidney Neoplasms (1)
pembrolizumab (1)
M.D. Anderson Cancer Center (1)
United States (1)
Aung Naing (1)
PMID 31533818, PMID 32188704, PMID 32303619, PMID 32534809, PMID 33415580, PMID 33427689, PMID 33491277, PMID 33770291, PMID 34241781, PMID 34725215, PMID 35618285, PMID 35999229, PMID 37568622, PMID 40212844, PMID 41143139, PMID 42342409